on Medicus Pharma Ltd (NASDAQ:MDCX)
Medicus Pharma Ltd. to Present at Maxim Growth Summit 2025
Medicus Pharma Ltd. (NASDAQ:MDCX), a biotech company focused on developing innovative therapeutics, will participate in the Maxim Growth Summit in New York City on October 22-23, 2025. Dr. Raza Bokhari, Executive Chairman & CEO, will engage in a Fireside Chat and provide updates on the company’s clinical programs. Medicus is advancing Skinject, aimed at treating basal cell carcinoma, and Teverelix, targeting advanced prostate cancer and urinary retention. Both assets represent significant market opportunities.
The conference will feature industry discussions, bringing together experts and leaders from various sectors. Medicus will also share developments from its ongoing studies in the US and UAE. Further, the recent acquisition of Antev enhances Medicus' position in the biotech sector, focusing on cardiovascular high-risk patients.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Medicus Pharma Ltd news